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Pharmaceutics
an inert shell resulting in the formation of microparticles or 
microcapsules or microspheres.[2] As multiparticulate drug 
delivery lead to wide and uniform distribution throughout 
GIT, a localized high concentration at a specific point may be 
avoided. In addition, multiparticulate delivery systems spread 
out more uniformly in the gastrointestinal tract. This results 
in more reproducible drug absorption and reduces local 
irritation when compared to single unit dosage form such as 
non disintegrating polymeric matrix tablets.  [3] Ibuprofen is a 
potent nonsteroidal antiinflammatory drug with a plasma half-
life of 1.8-2 h. It is used for relief of symptoms from arthritis, 
primary dysmenorrhea, fever and as analgesic especially where 
there is an inflammatory component. Ibuprofen appears to 
have the lowest incidence of gastrointestinal adverse drug 
reactions (ADRs) of all the non-selective NSAIDs. However, 
INTRODUCTION
Microencapsulation is well known method to delay and 
modify drug release characteristics. For oral use, it has 
been employed to sustain the drug release and to reduce or 
eliminate gastrointestinal tract irritation.[1] It is a process of 
enclosing micron size particles of solid or liquid or gases in 
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ABSTRACT
The present study was designed to investigate the effects of different variables on the release profile of ibuprofen 
microspheres formulated using modified emulsification method. Eight batches of microspheres (F1-F8) were 
prepared by applying 23 factorial design. The amount of sodium alginate, amount of calcium chloride, and 
amount of magnesium stearate were selected as formulation variables. All the batches were evaluated in terms 
of percentage yield, percentage encapsulation efficiency and in vitro release characteristics. The batch F7 was 
found to be optimum batch and was further characterized via scanning electron microscopy (SEM) and particle 
size analysis. Multiple linear regression was applied to confirm significant effect of each variable on release 
characteristics. The model developed in the present study can be effectively utilized to achieve the formulation 
with desired release characteristics.
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this only holds true at lower doses of ibuprofen, so over-the-
counter preparations of ibuprofen are generally labeled to 
advise a maximum daily dose of 1200 mg. Common adverse 
effects include nausea, dyspepsia, gastrointestinal bleeding, 
raised liver enzymes, diarrhea, dizziness, unexplained rash, salt 
and fluid retention, and hypertension.[4] Sodium alginate, a 
natural polysaccharide which is a mixture of polyuronic acids 
composed of residues of d-mannuronic acid and l-guluronic 
acid.[5] Alginates have the ability to form gels by reaction with 
divalent cations (Ca2+). The gelation and crosslinking of the 
polymers are mainly achieved by exchange of sodium ions 
from the guluronic acids with divalent cations, and the stacking 
of these guluronic groups to form the characteristic egg-box 
structure. The divalent cations bind to the α-L-guluronic acid 
blocks in the highly cooperative manner and the size of the 
cooperative unit is more than 20 monomers. Each alginate 
chain dimerizes to form junctions with many other chains 
and as the result gel network are formed.[6] Alginate shrinks 
at the low pH and the encapsulated drugs are not released. In 
gastric fluid, the hydrated sodium alginate is converted into 
porous, insoluble so-called alginic acid skin. Once passed into 
higher pH of the intestinal tract, the alginic skin is converted to 
soluble viscous layer. This pH dependent behavior of alginate 
can be exploited to customize release profiles.[6,7] To design a 
new formulation in the field of pharmaceutical dosage forms, 
it is very important to identify the parameters and variables 
in the method of preparation that may affect the properties 
of the new dosage form. Statistical design can be used for 
analyzing the influence of different factors on the properties 
of the system being studied.[8]
The present study was carried out to explore the potential 
of statistical design in optimizing the variables affecting the 
preparation of microspheres and release profile of ibuprofen 
from sodium alginate cross linked microspheres were also studied.
MATERIALS AND METHODS
Ibuprofen (Franklin Pharmaceuticals, Ludhiana, India), 
Sodium alginate, Calcium Chloride, Magnesium Stearate 
(Leochem Pvt. Ltd. India), Light Paraffin Wax, Hexane, 
Isopropyl Alcohol, (Rankem Ltd. India). All the chemicals 
were of analytical grade.
Methods
Preparation of  microspheres by modified emulsification method
The microspheres were prepared by using modified 
emulsification method as reported by Rahman et al.[9] The 
drug was dispersed in aqueous solution of sodium alginate 
(2.5-7.5 g) with magnesium stearate (0-2 g). The solution 
was emulsified in liquid paraffin containing span 80 using 
a mechanical stirrer at 1700 rpm for 1 h. After this, calcium 
chloride (2.5-5.0 g) solution (in isopropyl alcohol) was added to 
the emulsion at the rate of 2 ml/min. The emulsion was stirred 
for 10 more min. Microspheres formed in organic phase were 
removed by filtration and washed with hexane to remove 
liquid paraffin. Microspheres were then vacuum dried for 48 h.   
The composition of different batches is shown in Table 1.
Evaluation of  microspheres
Percentage yield: The percentage yield of microspheres was 
determined from the ratio of solidified total microspheres to 
the solid material used in the inner phase multiplied by 100.[10]
Percentage encapsulation efficiency: 20 mg microsphere 
sample was dissolved in 20 ml of phosphate buffer pH 
7.4 and kept for overnight. The solution was filtered to 
remove exhausted microspheres. The UV absorbance of 
the solution was measured using a UV spectrophotometer at 
269 nm. Percentage encapsulation efficiency was determined 
in duplicate for all batches using equation given below.[11] 
Encapsulation efficiency = (actual amount of Ibuprofen in 
sample/theoretical amount of Ibuprofen) × 100.
In vitro dissolution studies: In vitro dissolution studies 
of alginate microspheres was performed using USP II 
dissolution apparatus at 50 rpm at 37 ± 0.5°C in the 900 ml of 
gastric fluid (pH 1.4) for 2 h followed by 900 ml of intestinal 
fluid (pH 7.4) for 10 h. The sample (10 ml) withdrawn at 
specific intervals was replenished with equal volume of fresh 
dissolution media and filtered. The concentration of drug 
release from alginate microspheres as function of time was 
determined by using a UV spectrophotometer at 269 nm.
Scanning electron microscopy: Sample of microspheres 
were mounted onto the stubs using double-sided adhesive 
tape and then coated with gold palladium alloy (150-200 Å) 
using fine coat ion sputter (Joel, JPC-1100). The samples 
Table 1: Formulation of different batches and the per-
cent cumulative drug release








Amount of  




F1 -1 (2.5) -1 (2.5) -1 (0) 90.9
F2 -1 (2.5) -1 (2.5) 1 (2) 88
F3 -1 (2.5) 1 (5.0) -1 (0) 85
F4 -1 (2.5) 1 (5.0) 1 (2) 84
F5 1 (7.5) -1 (2.5) -1 (0) 81.1
F6 1 (7.5) -1 (2.5)  1 (2) 82.2
F7 1 (7.5) 1 (5.0) -1 (0) 72.24
F8 1 (7.5) 1 (5.0) 1 (2) 75.5
X-coefficient -4.6075 -3.1825 0.0575 82.3675 
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were subsequently analyzed under the scanning electron 
microscope for external morphology.
Particle size: Particle size of microspheres was analyzed 
using laser light diffraction technique (Malvern Instrument, 
Mastersizer 2000). The homogenous aqueous dispersion 
of microspheres was used for determining the particle size.
Statistical design
Most formulation studies involve the variation of one factor 
at a time, keeping other factors constant. Such an empirical 
method is acceptable only when factors are independent 
of one another. The factorial designs allow all factors to 
be varied simultaneously, thus enabling evaluation of effect 
of each variable at each level and showing interrelationship 
among them. A 23 factorial design was used sequentially 
to study the effect of independent formulation variables 
(amount of sodium alginate, amount of calcium chloride 
and amount of magnesium stearate) on the release profile 
of ibuprofen from sodium alginate microspheres.
RESULT AND DISCUSSION
The microspheres were prepared by modified emulsification 
method. Preliminary batches (A1-A4) were prepared 
to obtain discrete microspheres. The different variables 
i.e. amount of sodium alginate, calcium chloride and 
magnesium stearate were selected. The above batches 
were evaluated in terms of in vitro release studies and 
encapsulation efficiency. It was found that presence of 
magnesium stearate leads to good encapsulation efficiency. 
The increasing concentration of CaCl2 (up to 7.5 g) led to 
increased viscosity thereby affecting crosslinking process 
during microencapsulation. On the basis of these studies, 
further eight formulation batches (F1-F8) were prepared by 
applying a 23 factorial design by considering three factors i.e. 
the amount of polymer, sodium alginate (2.5 g and 7.5 g), 
calcium chloride (2.5  g and 5.0  g) and dispersing agent, 
magnesium stearate (0 g and 2 g) with two levels.
The % yield of different batches (F1-F8) was found to be 
66.6%-96.6% [Figure 1].
Increased encapsulation efficiency was observed in 
formulations at high level of magnesium stearate (F2, F4, 
F6, and F8). It may be due to the presence of magnesium 
stearate that was partly lost from inner phase. The high 
levels of sodium alginate lead to increased encapsulation 
efficiency whereas percentage encapsulation efficiency 
decreases with the increase in concentration of calcium 
chloride. For microspheres cross linked with low level 
of calcium chloride showed higher drug encapsulation 
efficiency in comparison to high levels of calcium chloride. 
This may be due to the instant gelling of sodium alginate 
on addition of calcium chloride and squeezing out of the 
aqueous phase from gel lattice [Figure 1].
The in vitro release profile from different batches is depicted 
in Figure 2. The batches F7 and F8 showed sustained 
release as compared to other batches. This may be due 
to increase in the density of the polymer matrix and the 
diffusional path length that the drug has to traverse. It may 
be due to high concentration of sodium alginate (F5-F8).
Scanning electron micrograph of batch F7 [Figure 3] 
showed that alginate microspheres are discrete and 
spherical in shape with a rough outer surface. The particle 
size of microspheres was found to be 6.8983 µm.
Data analysis
To determine the magnitude of contribution of different 
factors toward %CDR, multiple linear regression analysis 
was performed [Table 2]. It showed that % cumulative 
Figure 1: Percentage yield (series1) and percent encapsulation 
efficiency (series2)
Figure 2: In vitro dissolution profile of formulation batches (F1-F8)16   Journal of Young Pharmacists Vol 4 / No 1
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drug release decreases with increase in the both the 
concentration of sodium alginate and concentration of 
CaCl2. The effect of magnesium stearate on the %CDR 
was found to be negligible. The model, developed from 
multiple linear regression to estimate %cumulative drug 
release (Y) can be represented mathematically as:
%CDR (Y) = 82.37 − 4.607 * X1 – 3.182 * X2+0.057 * X3
Where Y = % cumulative drug release
X1 = Amount of Sodium alginate
X2 = Amount of CaCl2
X3 = Amount of magnesium stearate.
Analysis of variance (ANOVA) was applied to study the fitting 
and significance of mathematical model to estimate % CDR. 
The obtained F-value shows regression to be significant.
CONCLUSION
Microspheres are one of the microparticulate systems 
and are prepared to obtain prolonged or controlled drug 
delivery, to improve bioavailability or stability and to 
target drug to specific sites. Microspheres can also offer 
advantages like limiting fluctuation within therapeutic 
range, reducing side effects, decreasing dosing frequency 
and improving patient compliance. Microspheres of 
ibuprofen were prepared according to the 23 factorial 
design using modified emulsification method by selecting 
concentration of sodium alginate, magnesium stearate 
and calcium chloride as independent variables. Increasing 
polymer concentration led to more sustained release 
effect whereas presence of magnesium stearate improves 
the encapsulation efficiency. Calcium chloride can be 
increased up to certain limit above which encapsulation was 
decreased. Moreover, the effect of each variable on release 
characteristic was found to be significant as confirmed 
by data analysis. Retrospectively, the mathematical model 
developed in the present study can be used to design 
microspheres of desired release characteristic.
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